Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. (Q54635932)

1 June 2018

title

Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. (English)

1 reference

1 June 2018

0 references

7

Soumya Swaminathan

1 reference

1 June 2018

A K Hemanth Kumar

1

1 reference

1 June 2018

V Chandrasekaran

2

1 reference

1 June 2018

T Kannan

3

1 reference

1 June 2018

A Lakshmi Murali

4

1 reference

1 June 2018

J Lavanya

5

1 reference

1 June 2018

V Sudha

6

1 reference

1 June 2018

Geetha Ramachandran

8

1 reference

1 June 2018

publication date

20 September 2016

1 reference

1 June 2018

European Journal of Clinical Pharmacology

published in

1 reference

1 June 2018

volume

73

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

65-70

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s00228-016-2132-z

exact match

0 references

cites work

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Will China's nutrition transition overwhelm its health care system and slow economic growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Tuberculosis and diabetes mellitus: convergence of two epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Type 2 diabetes and multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Therapeutic drug monitoring in the treatment of tuberculosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis--a report from South India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-016-2132-Z

Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients

21 January 2018

1 reference

12 December 2020

Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients

1 reference

12 December 2020

Effects of glucose and ascorbic acid on absorption and first pass metabolism of isoniazid in rats

1 reference

12 December 2020

Tuberculosis complicated by diabetes mellitus at shanghai pulmonary hospital, china

1 reference

12 December 2020

Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis

1 reference

12 December 2020

Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors

1 reference

12 December 2020

Evaluation of an intermittent six-month regimen in new pulmonary tuberculosis patients with diabetes mellitus

1 reference

12 December 2020

Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance

1 reference

12 December 2020

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men

1 reference

12 December 2020

10.1007/S00228-016-2132-Z

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018